Onderneming Cytokinetics, Incorporated Deutsche Boerse AG
Aandelen
KK3A
US23282W6057
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
60,5 EUR | +0,83% | +4,31% | -18,24% |
26/04 | Cytokinetics benoemt Sung Lee tot CFO | MT |
26/04 | Cytokinetics, Incorporated benoemt Sung H. Lee tot Executive Vice President met ingang van 8 mei 2024 | CI |
Vakgebied
Aantal werknemers: 423
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Muscle Activators
100,0
%
| 95 | 100,0 % | 8 | 100,0 % | -92,04% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 95 | 100,0 % | 8 | 100,0 % | -92,04% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 01-07-98 |
Kari Loeser
CMP | Compliance Officer | - | 01-11-21 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Daniel Casper
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Fady Malik
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-98 |
Eric Terhaerdt
COO | Chief Operating Officer | - | 01-01-19 |
Diane Weiser
IRC | Investor Relations Contact | - | 01-04-15 |
John Faurescu
LAW | General Counsel | - | - |
Yulymae Dinapoli
HRO | Human Resources Officer | - | 01-11-21 |
Jeff Lotz
SAM | Sales & Marketing | - | 01-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20-11-20 |
Edward Kaye
BRD | Director/Board Member | 74 | 20-05-16 |
Santo Costa
BRD | Director/Board Member | 78 | 01-10-10 |
B. Parshall
BRD | Director/Board Member | 70 | 07-02-13 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 09-02-11 |
Sandy Smith
BRD | Director/Board Member | 77 | 05-03-12 |
John Henderson
CHM | Chairman | 79 | 01-02-09 |
Robert Blum
CEO | Chief Executive Officer | 60 | 01-07-98 |
Director/Board Member | 63 | 08-04-22 | |
Muna Bhanji
BRD | Director/Board Member | 61 | 17-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 104 576 087 | 103 964 682 ( 99,42 %) | 0 | 99,42 % |
Bedrijfsgegevens
Cytokinetics, Inc.
350 Oyster Point Boulevard
94080, South San Francisco
+650 624 3000
http://www.cytokinetics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,15% | 105 mld. | |
-1,08% | 104 mld. | |
+5,79% | 22,94 mld. | |
-11,55% | 22,34 mld. | |
-7,01% | 19,25 mld. | |
-37,08% | 17,08 mld. | |
-9,91% | 16,96 mld. | |
+7,55% | 14,16 mld. | |
+40,04% | 12,63 mld. |
- Beurs
- Aandelen
- Koers CYTK
- Koers KK3A
- Onderneming Cytokinetics, Incorporated